Home
Abbott India Ltd PE Ratio

Abbott India Ltd
NSE: ABBOTINDIA
PE
Key Highlights
- The P/E Ratio of Abbott India Ltd is 46.7 as of 19 Feb 14:26 PM .
- The P/E Ratio of Abbott India Ltd changed from 55.4 on March 2020 to 47.7 on March 2024 . This represents a CAGR of -2.95% over 5 years.
- The Latest Trading Price of Abbott India Ltd is ₹ 29585 as of 19 Feb 14:18 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Abbott India Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Abbott India Ltd
Company Fundamentals for Abbott India Ltd

Abbott India Ltd
NSE: ABBOTINDIA
Share Price
Market Price of Abbott India Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
18 Feb 2025 | 29318.15 |
17 Feb 2025 | 28582.7 |
14 Feb 2025 | 27859.05 |
13 Feb 2025 | 28370.9 |
12 Feb 2025 | 28769.45 |
11 Feb 2025 | 29136.95 |
10 Feb 2025 | 29662.2 |
07 Feb 2025 | 29796.4 |
06 Feb 2025 | 29101.95 |
05 Feb 2025 | 27784.65 |
SWOT Analysis Of Abbott India Ltd
BlinkX Score for Abbott India Ltd
Asset Value vs Market Value of Abbott India Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Abbott India Ltd | 62301 | 46.69 |
Sun Pharmaceuticals Industries Ltd | 408259 | 34.6 |
Divis Laboratories Ltd | 154917 | 74.9 |
Cipla Ltd | 119705 | 24.0 |
Torrent Pharmaceuticals Ltd | 103096 | 55.4 |
Dr Reddys Laboratories Ltd | 99951 | 18.6 |
Company | |
---|---|
Abbott India Ltd | 62301 |
Sun Pharmaceuticals Industries Ltd | 408259 |
Divis Laboratories Ltd | 154917 |
Cipla Ltd | 119705 |
Torrent Pharmaceuticals Ltd | 103096 |
Dr Reddys Laboratories Ltd | 99951 |
PE Ratio of Abbott India Ltd Explained
₹62301
Market cap
₹1334
Earnings
46.7X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Abbott India Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Abbott India Ltd
Historical Revenue, EBITDA and Net Profit of Abbott India Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Abbott India Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Abbott India Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Abbott India Ltd
About Abbott India Ltd
- Abbott India Ltd. is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.
- The Company sells its products through independent distributors primarily within India.
- It provides products and solutions across various therapeutic areas such as Women's Health, Gastroenterology, Central Nervous System, Metabolics, Multi-Specialty, Vaccines, Consumer Health, etc.
- Its global products include Brufen, Prothiaden, Thyronorm and Leptos. The company has four divisions.
- The Primary Care division markets products in the areas of pain management and gastroenterology.
Abbott India Ltd News Hub
Abbott India standalone net profit rises 13.01% in the June 2024 quarter
Net profit of Abbott India rose 13.01% to Rs 328.01 crore in the quarter ended June 2024 as against
Read more
08 Aug 24
Sensex, Nifty hit new life highs; auto shares in demand
The key equity indices further extended gains and hit fresh record highs in mid-morning trade. The N
Read more
20 Sept 24
Abbott India joins hand with Takeda Pharma to launch Vonoprazan tablets in India
Vonoprazan (PCAB or potassium competitive acid blocker) addresses severe acid related disorders like
Read more
20 Sept 24
Abbott India director resigns
Abbott India announced the resignation of Ashok Saini as Commercial Director - GenNext, Vaccines and
Read more
18 Oct 24